FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783018808> ?p ?o ?g. }

• W2783018808 abstract "Aging is associated with a decline in natural killer (NK) and natural killer T (NKT) cell function that may contribute to increased susceptibility to malignancy and infection. A preliminary investigation was conducted examining the hypothesis that arabinoxylan rice bran (Biobran/MGN-3), a denatured hemicellulose with known immunomodulatory activity, could counteract this decline in NK/NKT cell activity in geriatrics. A total of 12 healthy geriatric subjects of both sexes and over 56 years old, participated in a randomized, double-blind, placebo-controlled clinical trial. A total of six subjects served as control and six subjects ingested Biobran/MGN-3 (500 mg/day) for 30 days. The effect of Biobran/MGN-3 supplementation on NK/NKT cell activity was assessed using the degranulation assay. All study subjects were monitored for the development of any inadvertent side effects. In addition, the pharmacological effects of Biobran/MGN-3 on blood cell components and liver and kidney functions were also assessed. Results demonstrated that Biobran/MGN-3 had no effect on the total percentage of NK cells, however it enhanced the cytotoxic activity of induced NK cell expression of cluster of differentiation 107a, when compared with baseline values and with the placebo group (P<0.05). Furthermore, there were no side effects observed, indicating that Biobran/MGN-3 supplementation was safe at the utilized dosage and for the duration of administration. Various additional beneficial effects were observed, including improved mean corpuscular volume and reduced hepatic aspartate aminotransferase enzyme levels, which suggested improved liver function. It was concluded that Biobran/MGN-3 induces a significant increase in NK activity which may increase resistance to viral infections and cancers in the geriatric population. However, additional clinical trials should be conducted in the future to verify these findings." @default.
• W2783018808 created "2018-01-26" @default.
• W2783018808 creator A5003733555 @default.
• W2783018808 creator A5020069057 @default.
• W2783018808 creator A5046977556 @default.
• W2783018808 date "2018-01-08" @default.
• W2783018808 modified "2023-09-30" @default.
• W2783018808 title "Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double‑blind, placebo-controlled clinical trial" @default.
• W2783018808 cites W1495631259 @default.
• W2783018808 cites W1537436772 @default.
• W2783018808 cites W1866107945 @default.
• W2783018808 cites W1947944879 @default.
• W2783018808 cites W1966549570 @default.
• W2783018808 cites W1968736815 @default.
• W2783018808 cites W1970548110 @default.
• W2783018808 cites W1990863238 @default.
• W2783018808 cites W1992420760 @default.
• W2783018808 cites W1995549977 @default.
• W2783018808 cites W2001889286 @default.
• W2783018808 cites W2005651091 @default.
• W2783018808 cites W2015407094 @default.
• W2783018808 cites W2018833123 @default.
• W2783018808 cites W2018849077 @default.
• W2783018808 cites W2022069273 @default.
• W2783018808 cites W2041183431 @default.
• W2783018808 cites W2047717549 @default.
• W2783018808 cites W2054203685 @default.
• W2783018808 cites W2056493880 @default.
• W2783018808 cites W2058338960 @default.
• W2783018808 cites W2060464836 @default.
• W2783018808 cites W2064981157 @default.
• W2783018808 cites W2069169487 @default.
• W2783018808 cites W2073673356 @default.
• W2783018808 cites W2091389527 @default.
• W2783018808 cites W2094825474 @default.
• W2783018808 cites W2099562828 @default.
• W2783018808 cites W2104120663 @default.
• W2783018808 cites W2109379343 @default.
• W2783018808 cites W2114152712 @default.
• W2783018808 cites W2114187427 @default.
• W2783018808 cites W2116800574 @default.
• W2783018808 cites W2148115090 @default.
• W2783018808 cites W2157373425 @default.
• W2783018808 cites W2160712716 @default.
• W2783018808 cites W2169387365 @default.
• W2783018808 cites W2188113314 @default.
• W2783018808 cites W2189204137 @default.
• W2783018808 cites W2396809479 @default.
• W2783018808 cites W2531883437 @default.
• W2783018808 cites W2541073976 @default.
• W2783018808 cites W2549093693 @default.
• W2783018808 cites W2641847409 @default.
• W2783018808 cites W2765662304 @default.
• W2783018808 doi "https://doi.org/10.3892/etm.2018.5713" @default.
• W2783018808 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5795547" @default.
• W2783018808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29456638" @default.
• W2783018808 hasPublicationYear "2018" @default.
• W2783018808 type Work @default.
• W2783018808 sameAs 2783018808 @default.
• W2783018808 citedByCount "10" @default.
• W2783018808 countsByYear W27830188082018 @default.
• W2783018808 countsByYear W27830188082019 @default.
• W2783018808 countsByYear W27830188082021 @default.
• W2783018808 countsByYear W27830188082023 @default.
• W2783018808 crossrefType "journal-article" @default.
• W2783018808 hasAuthorship W2783018808A5003733555 @default.
• W2783018808 hasAuthorship W2783018808A5020069057 @default.
• W2783018808 hasAuthorship W2783018808A5046977556 @default.
• W2783018808 hasBestOaLocation W27830188081 @default.
• W2783018808 hasConcept C126322002 @default.
• W2783018808 hasConcept C142724271 @default.
• W2783018808 hasConcept C1491633281 @default.
• W2783018808 hasConcept C154317977 @default.
• W2783018808 hasConcept C181199279 @default.
• W2783018808 hasConcept C202751555 @default.
• W2783018808 hasConcept C203014093 @default.
• W2783018808 hasConcept C204787440 @default.
• W2783018808 hasConcept C27081682 @default.
• W2783018808 hasConcept C2778102761 @default.
• W2783018808 hasConcept C2779049480 @default.
• W2783018808 hasConcept C42407357 @default.
• W2783018808 hasConcept C55493867 @default.
• W2783018808 hasConcept C71924100 @default.
• W2783018808 hasConcept C86803240 @default.
• W2783018808 hasConcept C90924648 @default.
• W2783018808 hasConcept C98274493 @default.
• W2783018808 hasConceptScore W2783018808C126322002 @default.
• W2783018808 hasConceptScore W2783018808C142724271 @default.
• W2783018808 hasConceptScore W2783018808C1491633281 @default.
• W2783018808 hasConceptScore W2783018808C154317977 @default.
• W2783018808 hasConceptScore W2783018808C181199279 @default.
• W2783018808 hasConceptScore W2783018808C202751555 @default.
• W2783018808 hasConceptScore W2783018808C203014093 @default.
• W2783018808 hasConceptScore W2783018808C204787440 @default.
• W2783018808 hasConceptScore W2783018808C27081682 @default.
• W2783018808 hasConceptScore W2783018808C2778102761 @default.
• W2783018808 hasConceptScore W2783018808C2779049480 @default.
• W2783018808 hasConceptScore W2783018808C42407357 @default.
• W2783018808 hasConceptScore W2783018808C55493867 @default.
• W2783018808 hasConceptScore W2783018808C71924100 @default.

• next